Home / Nervous system / Fentanyl
ATC N02AB03 · Analgesics
Fentanyl shortage
As of 31 Oct 2026, Fentanyl has a reported shortage in 4 of the 5 countries we track (Italy, Spain, Austria, Belgium), covering 28 products.
Countries4/5
Products28packs or presentations
Short since17 Jul 20233.3 years ago
Earliest return1 Nov 2026company estimate
No return date22products
Main reasonManufacturing problem
Timeline
ItalySpainAustriaBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | FENTANIL ZENTIVA | ZENTIVA ITALIA S.R.L. | 17 Jul 2023 | not given | Manufacturing problem Problemi produttivi |
| IT | FENTANIL ZENTIVA | ZENTIVA ITALIA S.R.L. | 11 Sep 2023 | not given | Manufacturing problem Problemi produttivi |
| IT | FENTANIL ZENTIVA | ZENTIVA ITALIA S.R.L. | 16 Oct 2023 | not given | Manufacturing problem Problemi produttivi |
| IT | EFFENTORA | PHOENIX LABS UNLIMITED COMPANY | 1 Feb 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | EFFENTORA | PHOENIX LABS UNLIMITED COMPANY | 1 Feb 2026 | 15 May 2027 | Manufacturing problem Problemi produttivi |
| IT | EFFENTORA | PHOENIX LABS UNLIMITED COMPANY | 17 Mar 2026 | 15 May 2027 | Regulatory or licensing Problemi regolatori |
| IT | EFFENTORA | PHOENIX LABS UNLIMITED COMPANY | 15 Jun 2026 | not given | Regulatory or licensing Problemi regolatori |
| IT | DOGETIC | SANDOZ S.P.A. | 26 Jun 2026 | not given | Increased demand Elevata richiesta: distribuzione contingentata |
| IT | EFFENTORA | PHOENIX LABS UNLIMITED COMPANY | 29 Jun 2026 | not given | Regulatory or licensing Problemi regolatori |
| IT | ACTIQ | PHOENIX LABS UNLIMITED COMPANY | 30 Jun 2026 | 1 Nov 2026 | Manufacturing problem Problemi produttivi |
| IT | EFFENTORA | PHOENIX LABS UNLIMITED COMPANY | 8 Jul 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | EFFENTORA | PHOENIX LABS UNLIMITED COMPANY | 10 Jul 2026 | not given | Regulatory or licensing Problemi regolatori |
| IT | FENROO | EG S.P.A. | 31 Jul 2026 | not given | Increased demand Elevata richiesta |
| IT | FENROO | EG S.P.A. | 31 Jul 2026 | not given | Increased demand Elevata richiesta |
| IT | FENROO | EG S.P.A. | 31 Jul 2026 | not given | Increased demand Elevata richiesta |
| IT | FENPATCH | RATIOPHARM GMBH | 1 Sep 2026 | not given | Manufacturing problem Problemi produttivi (carenza relativa solo al canale retail) |
| IT | EFFENTORA | PHOENIX LABS UNLIMITED COMPANY | 18 Sep 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | FENTANIL ARISTO | ARISTO PHARMA GMBH | 20 Oct 2026 | not given | Increased demand Elevata richiesta |
| ES | FENTICERTA 100 MICROGRAMOS COMPRIMIDOS SUBLINGUALES EFG , 10 comprimidos | Sandoz Farmaceutica S.A. | 16 Jun 2026 | 15 Nov 2026 | Not stated |
| ES | EFFENTORA 100 microgramos COMPRIMIDOS BUCALES, 28 comprimidos | Phoenix Labs Unlimited Company | 23 Sep 2026 | not given | Not stated |
| ES | FENTICERTA 200 MICROGRAMOS COMPRIMIDOS SUBLINGUALES EFG 10 comprimidos | Sandoz Farmaceutica S.A. | 22 Oct 2026 | 15 Nov 2026 | Not stated |
| AT | Durogesic 100 Mikrogramm/Stunde - Transdermales Pflaster, 5 Stück | Janssen-Cilag Pharma GmbH | 25 Jun 2025 | not given | Quality problem or recall Qualitätsprobleme bei der Herstellung |
| AT | Durogesic 12 Mikrogramm/Stunde - Transdermales Pflaster, 5 Stück | Janssen-Cilag Pharma GmbH | 25 Jun 2025 | not given | Quality problem or recall Qualitätsprobleme bei der Herstellung |
| AT | Durogesic 50 Mikrogramm/Stunde - Transdermales Pflaster, 5 Stück | Janssen-Cilag Pharma GmbH | 21 Aug 2025 | not given | Quality problem or recall Qualitätsprobleme bei der Herstellung |
| AT | Durogesic 75 Mikrogramm/Stunde - Transdermales Pflaster, 5 Stück | Janssen-Cilag Pharma GmbH | 31 Oct 2025 | not given | Quality problem or recall Qualitätsprobleme bei der Herstellung |
| AT | Fentabucc akut 100 Mikrogramm Buccaltabletten, 28 Stück | Genericon Pharma Ges.m.b.H. | 10 Feb 2026 | not given | Increased demand Erhöhter Mehrbedarf |
| AT | Fentanyl Actavis 75 Mikrogramm/h transdermales Pflaster, 5 Stück | Actavis Group PTC ehf. | 21 Sep 2026 | not given | Manufacturing problem Verzögerung bei der Herstellung |
| BE | Matrifen 12 µg/h transderm. patch sachet 2 (1,38 mg/4,2 cm²) | Istituto Gentili | 2 Oct 2026 | 31 Dec 2027 | Other Other reason |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.